Authorization

Osmotica Pharmaceuticals plc to Provide Third Quarter 2019 Business and Financial Update on November 15, 2019

BRIDGEWATER, N.J., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (a??Osmoticaa?? or the a??Companya??) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the Company will release its 2019 third quarter financial results on Thursday, November 14, 2019, after the close of the U.S. financial markets.
Brian Markison, Chief Executive Officer, James a??JDa?? Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date



Friday, November 15, 2019



Time



8:30 a.m. EST



Toll free (U.S.)



(866) 672-5029



International



(409) 217-8312



Webcast (live and replay)



www.osmotica.comA under the a??Investor & Newsa?? section

The webcast will be archived for 30 days at the aforementioned URL.About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Companya??s diversified branded portfolio, and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations.A Osmotica has operations in the United States, Argentina, and Hungary.A 
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Ноябрь 2019    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
252627282930